Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil in Men With Depression and Erectile Dysfunction
NCT00661219Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2002
- Primary completion
- Nov 2003
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Vardenafil with Placebo (2 arms). Primary endpoints: Change from baseline in the International Index of Erectile Function - Erectile Function domain score at 12 weeks and Change from baseline in the Hamilton Depression Rating Scale (17-item) total score at 12 weeks. Started Dec 2002; status: completed.
02
Drugs
vardenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00661219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661219.